AI assistant
Sending…
Novonesis AS — Share Issue/Capital Change 2017
Jan 24, 2017
Preview isn't available for this file type.
Download source fileOn January 25, 2017, Novozymes will initiate a stock buyback program as
announced in Company announcement No. 1 of January 18, 2017. Under the program
Novozymes will buy back B shares worth up to DKK 2 billion in total during the
remainder of 2017, corresponding to around 8.1 million B shares at the current
share price. The program is contingent upon no major strategic initiatives
being decided upon that will require a significant amount of capital, for
example a major acquisition.
Read the full announcement in PDF
More from Novonesis AS
Director's Dealing
2026
May 6
Director's Dealing
2026
May 6
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 11
Director's Dealing
2026
Mar 11
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27